10x Genomics, Inc. TXG Single Cell — Total Revenue
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by 10x Genomics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: 10x Genomics, Inc.’s 10-K, filed February 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about 10x Genomics, Inc.'s single cell — total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is 10x Genomics, Inc.'s single cell — total revenue?
- 10x Genomics, Inc. (TXG) reported single cell — total revenue of $90.8M in Q4 2025.
- How has 10x Genomics, Inc.'s single cell — total revenue changed year-over-year?
- 10x Genomics, Inc.'s single cell — total revenue decreased by 2.4% year-over-year, from $93.08M to $90.8M.
- What is the long-term trend for 10x Genomics, Inc.'s single cell — total revenue?
- Over 2 years (2023 to 2025), 10x Genomics, Inc.'s single cell — total revenue has grown at a -7.0% compound annual growth rate (CAGR), from $420.32M to $363.21M.
- What does single cell — total revenue mean?
- This metric captures the aggregate revenue derived from the entire single-cell analysis segment, encompassing both hardware instruments and related consumables or software. It reflects the overall commercial performance and market penetration of the company's primary life science technology offerings. Analyzing this total provides insight into the segment's contribution to the company's consolidated top-line growth and its competitive positioning in the genomics market.